Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Knut Jørgen Labori

Professor

Oslo University Hospital

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Epidemiology Epidemiology professors in Norway

Articles (18)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Collaborators (19)

Jakob Kirkegård

VIP, Associate Professor

Aarhus University Hospital

DENMARK

View details

Uwe Pelzer

GERMANY

View details

Oliver Strobel

Head of Department, Professor of Visceral Surgery

Medical University of Vienna

AUSTRIA

View details

Alessandro Zerbi

Director

Humanitas University

ITALY

View details

Yuan-Haw Andrew Wu

Johns Hopkins University

UNITED STATES

View details

Caroline Verbeke

Prof. Dr

University of Oslo

NORWAY

View details

Ammar Javed

Assistant Professor

NYU Langone Health

UNITED STATES

View details

Pål-Dag Line

Professor

University of Oslo

NORWAY

View details

Hanna Seppänen

University of Helsinki

FINLAND

View details

Maria João Amaral

University of Coimbra

PORTUGAL

View details

Gennaro Nappo

Humanitas University

ITALY

View details

Marcus Holmberg

Head Emergency and Upper GI Surgery

SWEDEN

View details

Nigel Jamieson

University of Glasgow

UNITED KINGDOM

View details

Savio George Barreto

Flinders University

AUSTRALIA

View details

Akseli Bonsdorff

University of Helsinki

FINLAND

View details

Ilkka Helanterä

University of Helsinki

FINLAND

View details

Manoj Amrutkar

Scientist

Oslo University Hospital

NORWAY

View details

Elizabeth Pando

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Daisuke Hashimoto

Kansai Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Knut Jørgen Labori

Research Interests

Explore related searches

Articles (18)

The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy Mortality

Reoperation after pancreatoduodenectomy: indications, surgical approaches, outcomes, and temporal trends

Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study

Impact of neoadjuvant therapy on short-term outcomes after left pancreatectomy: A propensity score–matched international multicenter study

International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model

Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study

Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX

Classification of postoperative pancreatic fistula after left pancreatectomy: international multicentre cohort study

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial.

Postoperative Hyperamylasemia (POH) Is an Early Predictor of Pancreatic Fistula Occurrence and Severity After Distal Pancreatectomy Results from a European Multicentric Study

Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer

ASO Author Reflections: From BRPC to LAPC-Rethinking Resectability in Pancreatic Cancer

Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial

Association between baseline quality of life and survival in patients with non-metastatic, advanced pancreatic cancer

Prognostic and monitoring potential of circulating tumor DNA in resectable pancreatic cancer

Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX

Echinococcosis in a non-endemic country – 20-years’ surgical experience from a Norwegian tertiary referral Centre

Collaborators (19)

Jakob Kirkegård

Uwe Pelzer

Oliver Strobel

Alessandro Zerbi

Yuan-Haw Andrew Wu

Caroline Verbeke

Ammar Javed

Pål-Dag Line

Hanna Seppänen

Maria João Amaral

Gennaro Nappo

Marcus Holmberg

Nigel Jamieson

Savio George Barreto

Akseli Bonsdorff

Ilkka Helanterä

Manoj Amrutkar

Elizabeth Pando

Daisuke Hashimoto

Make your next move.